CAR-T Cell Therapy Market – Global Industry Analysis and Forecast (2022-2029)


Global CAR-T Cell Therapy Market size is expected to grow at 34% throughout the forecast period, reaching nearly US$ 20.42 Bn. by 2029.

Global CAR-T Cell Therapy Market Overview:

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is a type of cell-based gene therapy it involves altering the genes inside T cells to help them attack cancer.

Global CAR-T Cell Therapy Market

To know about the Research Methodology :- Request Free Sample Report

Global CAR-T Cell Therapy Market Dynamics:

Rising prevalence of cancer coupled with high demand for effective treatment to cure cancer is driving the market growth.

Recent studies suggest that over 1.7 million new cancer patients are recorded in U.S. alone and nearly 4.3 million in China. A rising number of adults and children developing cancer is expected to increase demand for effective and reliable therapeutic treatment approach for the improvement of the quality of patient’s lives.

Moreover, the development of new and effective therapy options to cure symptoms of the disease is also contributing to the growth of the CAR-T cell therapy market. Increasing government initiatives for improving health care infrastructure and promoting research for cell therapy in cancer is fueling the growth of the market. In December 2021, the National Cancer Advisory Board authorized US$ 1.8 Bn in funding for Cancer Moonshot, which is an initiative taken up to accelerate research with an aim to make more therapies available to patients with cancer. However, High costs associated with CAR-T therapy and lack of cost-effective therapies for cancer have influenced the health conditions of the population and have led to a low average life expectancy. These factors may hinder the market growth.

The report has profiled eighteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology is analyzed and report has come up with recommendations for future hot spot in APAC region.

Global CAR-T Cell Therapy Market Segment Analysis:

The global CAR-T Cell Therapy market is segmented on the basis of Target Antigen, Therapeutic Application and End-Users.

Based on Target Antigen, CD19/CD22 target antigens are estimated to hold the largest market share. The strong growth is creditable to the high approval rate of the antigens and their commercialization. On the other hand, BCMA (B-cell maturation antigen) segment is anticipated to record a robust growth rate growth over the forecasted years.

Based on Therapeutic Application, diffuse large B-cell lymphoma is expected to dominate the global market. It accounted for 56.1% of the total market share in 2021. The Multiple Myeloma (MM) segment is expected to register a significant growth rate over the forecast period.

Global CAR-T Cell Therapy Market Regional Insights:

North America is expected to dominate global market over forecast years.

North America’s market growth is attributed due to the rapid development and launch of new therapies for the treatment of cancer by key players in the market. For instance, in August 2021, the U.S. Food and Drug Administration (FDA) approved Kymriah, a CAR-T cell therapy to treat pediatric and young adult patients suffering from a form of acute lymphoblastic leukemia. Moreover, a large patient pool suffering from cancer in the U.S. and Canada is expected to further fuel the growth of the region in the global market. For instance, according to the Centers for Disease Control and Prevention (CDC) 2021, around 171,000 patients with blood cancer are diagnosed each year in the U.S. Europe is expected to hold the second-largest market during the forecast period.

Asia Pacific is expected to witness lucrative growth during forecast period.

Asia Pacific is expected to exhibit the highest growth over the forecast period, owing to the increasing number of global players collaborating and signing research as well as manufacturing contracts for CAR-T cell therapies with local players in the region. For instance, Cesca Therapeutics signed a license agreement with China-based, Boyalife Group, in March 2021, for CAR-T cell-related bioprocessing, development, and manufacturing outsourcing.

The report also helps in understanding Global CAR-T Cell Therapy Market dynamics, structure by analyzing the market segments and project the Global CAR-T Cell Therapy Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global CAR-T Cell Therapy Market make the report investor’s guide.

Global CAR-T Cell Therapy Market, Key developments:

• In February 2021, the U.S. FDA granted approval of Breyanzi (lisocabtagene maraleucel) to Juno Therapeutics, a Bristol-Myers Squibb company. Breyanzi is approved for the treatment of adults with relapsed or refractory large-B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.

• In July 2020, the U.S. FDA approved the third CAR-T cell therapy, approving Kite Pharma’s brexucabtagene autoleucel, sold as Tecartus. It is the first CAR-T therapeutic to treat relapsed or refractory mantle cell lymphoma (MCL). The approval of these early CAR-T cell therapies has opened the gates for many other types of cell and gene therapies to claim respect, from regulators, as well as the scientific and medical community at large.

Global CAR-T Cell Therapy Market Scope: Inquire before buying






Global Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 1.96 Bn.




Forecast Period 2022 to 2029 CAGR:
34%
Market Size in 2029:
US $ 20.42Bn.




 Segments Covered:
by Target Antigen
• CD 19/ CD 22
• HER 1
• BCMA
• Others




by Therapeutic Application
• Acute Lymphocytic Leukemia
• Diffuse large B-cell lymphoma
• Chronic Lymphocytic Leukemia
• Hepatocellular Carcinoma
• Others




by End-Users
• Hospitals
• Cancer Research Institutes
• Clinics & Ambulatory Centers






Global CAR-T Cell Therapy Market, by Region:

• North America
• Europe
• South America
• MEA
• APAC

Global CAR-T Cell Therapy Market, Key player:

• Gilead Sciences
• Novartis AG
• Gracell Biotechnology Ltd
• Aeon Therapeutics
• CARsgen Therapeutics
• Daiichi Sankyo
• Celegne
• Otsuka Pharmaceutical
• Biocon
• Ono Pharmaceutical
• Japan Tissue Engineering
• Nipro Corporation
• Takeda Pharmaceutical Company
• Astellas Pharma
• PersonGen Biomedicine
• Hebei Senlang Biotech
• Eli Lilly and Company
• Johnson & Johnson Private Limited

Frequently Asked Questions:

1. Which region has the largest share in Global CAR-T Cell Therapy Market?
Ans: North America region held the highest share in 2021.

2. What is the growth rate of Global CAR-T Cell Therapy Market?
Ans: The Global CAR-T Cell Therapy Market is growing at a CAGR of 34% during forecasting period 2022-2029.

3. What is scope of the Global CAR-T Cell Therapy market report?
Ans: Global CAR-T Cell Therapy Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global CAR-T Cell Therapy market?
Ans: The important key players in the Global CAR-T Cell Therapy Market are – Gilead Sciences, Novartis AG, Gracell Biotechnology Ltd, Aeon Therapeutics, CARsgen Therapeutics, Daiichi Sankyo, Celegne, Otsuka Pharmaceutical, Biocon, Ono Pharmaceutical, Japan Tissue Engineering, Nipro Corporation, Takeda Pharmaceutical Company, Astellas Pharma, PersonGen Biomedicine, Hebei Senlang Biotech, Eli Lilly and Company, and Johnson & Johnson Private Limited

5. What is the study period of this market?
Ans: The Global CAR-T Cell Therapy Market is studied from 2021 to 2029. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global CAR-T Cell Therapy Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2021
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the CAR-T Cell Therapy Market
3.4. Geographical Snapshot of the CAR-T Cell Therapy Market, By Manufacturer share
4. Global CAR-T Cell Therapy Market Overview, 2021-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global CAR-T Cell Therapy Market
5. Supply Side and Demand Side Indicators
6. Global CAR-T Cell Therapy Market Analysis and Forecast, 2021-2029
6.1. Global CAR-T Cell Therapy Market Size & Y-o-Y Growth Analysis.
7. Global CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
7.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
7.1.1. CD 19/ CD 22
7.1.2. HER 1
7.1.3. BCMA
7.1.4. Others
7.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
7.2.1. Acute Lymphocytic Leukemia
7.2.2. Diffuse large B-cell lymphoma
7.2.3. Chronic Lymphocytic Leukemia
7.2.4. Hepatocellular Carcinoma
7.2.5. Others
7.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
7.3.1. Hospitals
7.3.2. Cancer Research Institutes
7.3.3. Clinics & Ambulatory Centers
8. Global CAR-T Cell Therapy Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
9.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
9.1.1. CD 19/ CD 22
9.1.2. HER 1
9.1.3. BCMA
9.1.4. Others
9.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
9.2.1. Acute Lymphocytic Leukemia
9.2.2. Diffuse large B-cell lymphoma
9.2.3. Chronic Lymphocytic Leukemia
9.2.4. Hepatocellular Carcinoma
9.2.5. Others
9.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
9.3.1. Hospitals
9.3.2. Cancer Research Institutes
9.3.3. Clinics & Ambulatory Centers
10. North America CAR-T Cell Therapy Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
11.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
11.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
11.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
12. Canada CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
12.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
12.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
12.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
13. Mexico CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
13.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
13.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
13.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
14. Europe CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
14.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
14.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
14.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
15. Europe CAR-T Cell Therapy Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
16.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
16.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
16.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
17. France CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
17.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
17.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
17.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
18. Germany CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
18.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
18.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
18.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
19. Italy CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
19.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
19.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
19.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
20. Spain CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
20.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
20.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
20.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
21. Sweden CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
21.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
21.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
21.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
22. CIS Countries CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
22.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
22.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
22.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
23. Rest of Europe CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
23.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
23.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
23.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
24. Asia Pacific CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
24.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
24.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
24.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
25. Asia Pacific CAR-T Cell Therapy Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
26.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
26.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
26.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
27. India CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
27.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
27.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
27.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
28. Japan CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
28.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
28.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
28.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
29. South Korea CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
29.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
29.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
29.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
30. Australia CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
30.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
30.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
30.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
31. ASEAN CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
31.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
31.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
31.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
32. Rest of Asia Pacific CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
32.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
32.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
32.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
33. Middle East Africa CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
33.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
33.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
33.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
34. Middle East Africa CAR-T Cell Therapy Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
35.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
35.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
35.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
36. GCC Countries CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
36.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
36.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
36.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
37. Egypt CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
37.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
37.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
37.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
38. Nigeria CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
38.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
38.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
38.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
39. Rest of ME&A CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
39.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
39.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
39.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
40. South America CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
40.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
40.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
40.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
41. South America CAR-T Cell Therapy Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
42.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
42.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
42.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
43. Argentina CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
43.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
43.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
43.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
44. Rest of South America CAR-T Cell Therapy Market Analysis and Forecasts, 2021-2029
44.1. Market Size (Value) Estimates & Forecast By Target Antigen, 2021-2029
44.2. Market Size (Value) Estimates & Forecast By Therapeutic Application, 2021-2029
44.3. Market Size (Value) Estimates & Forecast By End-Users, 2021-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global CAR-T Cell Therapy Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile : Key Players
45.3.1. Gilead Sciences
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Novartis AG
45.3.3. Gracell Biotechnology Ltd
45.3.4. Aeon Therapeutics
45.3.5. CARsgen Therapeutics
45.3.6. Daiichi Sankyo
45.3.7. Celegne
45.3.8. Otsuka Pharmaceutical
45.3.9. Biocon
45.3.10. Ono Pharmaceutical
45.3.11. Japan Tissue Engineering
45.3.12. Nipro Corporation
45.3.13. Takeda Pharmaceutical Company
45.3.14. Astellas Pharma
45.3.15. PersonGen Biomedicine
45.3.16. Hebei Senlang Biotech
45.3.17. Eli Lilly and Company
45.3.18. Johnson & Johnson Private Limited
46. Primary Key Insights

About This Report

Report ID 98045
Category Healthcare
Published Date Oct 2022
Updated Date